Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pevion Biotech AG

www.pevion.com

Latest From Pevion Biotech AG

Life Science Start-Ups: Tech Transfer Deals, July-August 2014

Derived from Strategic Transactions, a fully searchable premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June 2014.

BioPharmaceutical Medical Device

Deals Shaping the Medical Industry (10/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

CSL acquires option to Pevion's candidiasis vaccine

In the first deal for the product, CSL has acquired the right of first refusal to a licence to commercialise Pevion Biotech's therapeutic vaccine against Candida albicans, PEV7, in Australia and New Zealand.

Infectious Diseases Cancer

Former Sanofi Pasteur MSD president joins Pevion's board

Pevion Biotech has appointed the former president of Sanofi-Pasteur MSD, Didier Hoch, to its board of directors. Mr Hoch served in the president role at Sanofi-Pasteur MSD from 2000-10, and has previously worked as vice-president Africa & Middle East at Aventis Pharma International and deputy general manager at Rhône-Poulenc Rorer France. Pevion is a Swiss vaccine company developing vaccines based on its virosome technology.

France Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Pevion Biotech Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Pevion Biotech AG
  • Senior Management
  • Evert Kueppers, CEO
    Christian Moser, PhD, Head, Rsch.
    Urs Berchtold, Head, Fin.
  • Contact Info
  • Pevion Biotech AG
    Phone: (41) 31 550 44 44
    Worblentalstrasse 32
    Berne, CH-3063
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register